Slide CordenPharma scientist in lab coat holding binder for News & Press header with white global connectivity background

NEWS & PRESS


News

May 9, 2022

CordenPharma COVID-19 Customer Letter

May 09, 2022
COVID-19 > Read CEO Dr. Michael Quirmbach's Customer Letter Response to COVID-19.
April 13, 2022

CordenPharma Receives Supplier Recognition Award from Esperion

April 13, 2022
CordenPharma Receives Supplier Recognition Award from Esperion at DCAT Week 2022.
March 10, 2022

CordenPharma Donates to Support Disaster Relief Efforts in the Ukraine

March 10, 2022
CordenPharma donates a combined €100,000 to support disaster relief efforts in the Ukraine.
March 3, 2022

CEO Michael Quirmbach Talks Expanded Footprint, Green Chemistry & Growth

March 3, 2022
Global Business Reports Interview: CEO Michael Quirmbach Talks 2022 Expanded Footprint & Growth Strategy
January 13, 2022

DCAT Value Chain Insights Interviews CEO Michael Quirmbach on 2022 CDMO Key Issues

January 13, 2021
DCAT Value Chain Insights Interview: CEO Michael Quirmbach Talks Trends & Issues in the CDMO Sector for 2022.
November 23, 2021

CordenPharma Chenôve Attracts Top Talent in The Pharmaceutical Industry

November 23, 2021
Interview with CordenPharma Chenôve, Yves Michon, Managing Director
October 18, 2021

CordenPharma 15 Year Anniversary

Edition 3 / October 2021
CordenPharma 15 Year Anniversary > Celebrating on CordenPharma Day - October 1, 2021
June 23, 2021

CEO Michael Quirmbach Talks New Funding & Importance of CDMO End-to-End Services

June 23, 2021
Global Business Reports Interview: CEO Michael Quirmbach Talks Funding & CDMO End-to-End Services
April 28, 2021

When the EU’s Covid-19 Vaccine Drive Stumbled, It Turned to Mr. Fixit

April 28, 2021
> Wall Street Journal: When the EU’s Covid-19 Vaccine Drive Stumbled, It Turned to Mr. Fixit
April 21, 2021

Vaccine: Dr. Clemens Horn, The Magician Chemist of CordenPharma

April 21, 2021
Vaccine: Dr. Clemens Horn, The Magician Chemist of CordenPharma
April 19, 2021

Revolo Bio & CordenPharma Sign Manufacturing Agreement for Peptide API Supply

April 19, 2021
News > Revolo Bio & CordenPharma Sign MSA for the Supply of Peptides APIs for ‘1104 Clinical Trials
April 5, 2021

EU Commissioner Thierry Breton Visits CordenPharma Chenôve on April 4, 2021

April 5, 2021
EU Commissioner Thierry Breton visits CordenPharma Chenôve on Easter.
March 24, 2021

Nanos & CordenPharma Sign New Collaboration Agreement

March 24, 2021
News > CordenPharma and Nanos of South Korea sign a new collaboration agreement relating to the production of Peptides.
January 22, 2021

CEO Magazine Interviews CordenPharma CEO & President Michael Quirmbach

Jan 22, 2021
CEO Magazine Interviews CordenPharma CEO & President Michael Quirmbach
December 8, 2020

Eiger BioPharmaceuticals: FDA Approval of Zokinvy™ (Ionafarnib)

December 8, 2020
News > CordenPharma congratulates Eiger BioPharmaceuticals on their recent FDA Approval of Zokinvy (lonafarnib).